Search

You searched for "cytology"

787 results found

Increasing PSA after negative prostate biopsy - solving the clinical puzzle

1 November 2014 | | Urologic Oncology | Anterior cancer, Multiparametric magnetic resonance imaging, PCA3, Repeat prostate biopsy, Transperineal prostate biopsy, Transrectal ultrasonography
There are standard guidelines for first transrectal ultrasonography (TRUS) guided biopsy in a patient presenting with elevated prostate-specific antigen (PSA) or suspicious digital rectal examination (DRE) findings. Patients are generally warned before a TRUS biopsy in respect of a false...

PSM increases risk of recurrence after PN for high-risk renal tumours

1 January 2017 | | Urologic Oncology | Carcinoma, renal cell, kidney neoplasms, laparoscopy, nephrectomy
Positive surgical margins (PSM) for solid organ malignancies are associated with adverse oncological outcomes. However, for RCC the prognostic significance of PSM after partial nephrectomies (PN) remains a matter of debate. As PN is more increasingly being used to excise...

Repeat transurethral resection in non-muscle invasive bladder cancer

1 November 2018 | | Uroradiology | Bladder, Cancer, Detrusor, Muscle, Progression, Re-resection, Recurrence, Upstaging
The authors felt this is a big problem because there is no standardised practice on re-resection following initial transurethral resection of bladder tumour (TURBT). Getting detrusor muscle in the first specimen is thought to be important. However muscle is not...

39th Congress of the Société Internationale d'Urologie

17 October 2019 -20 October 2019
The SIU is set to host its 39th Congress in the historic capital of Europe: Athens, Greece! Join us 17-20 October for expert coverage of the most pertinent issues in urology. Plan to arrive early and participate in additional programming...

Thomas Molyneux and the lost bodkin

1 January 2019 | | Endourology and Stones, Technological Developments
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). In an earlier article we looked at one of the medals in the...

Urological Society of Australia and New Zealand (USANZ) 2019

11 April 2019 -16 April 2019
By Munad Khan, Urology Registrar, Redcliffe Hospital, Brisbane, Australia. This year's USANZ ASM was held in sunny Brisbane, Queensland. This annual meeting showcased important academic developments from a range of Australasian urologists and aspiring trainees, supported by an impressive international...

BAUN Annual Conference 2022

6 November 2022 -8 November 2022
Registration is now open for the BAUN 2022 Annual ConferenceThis year's annual conference will focus on ‘Showcasing the Impact of Urological Nursing’.The main conference will takes place on 7-8 November. In addition, our popular pre-conference workshops will take place on...

A review of the diagnosis and management of urethral caruncles

1 November 2017 | | Functional Urology
Introduction The innocuous urethral caruncle is the most common benign urethral lesion in females. It can pose a significant challenge to urologists due to the plethora of differentials and poor evidence surrounding management. In 1926, Ferrier eloquently described the macroscopic...

Focal therapy for prostate cancer – ready for prime time?

1 November 2016 | | Basic Science Research, Urologic Oncology
The current therapeutic ratio for radical therapy in many men with localised prostate cancer is not ideal. For a significant side-effect profile, there seems to be a small survival benefit over a 10-15 year period. A strategy that might balance...

Fournier’s gangrene

1 May 2015 | | Infection
Introduction Fournier’s gangrene (FG) is a rare but fulminant form of infective necrotising fasciitis affecting the perineum and external genitalia, which can rapidly progress along fascial planes. It most commonly affects men, but can occur in women and children, with...

Trials offering cytoreductive surgery for men with de novo synchronous metastatic prostate cancer

8 November 2021 | | Basic Science Research, Urologic Oncology
Life expectancy in men diagnosed with de novo synchronous metastatic hormone-sensitive prostate cancer (mHSPC) has risen to a median of 4.8 years with upfront systemic agents (such as docetaxel) in addition to standard androgen deprivation therapy (ADT) [1-3]. Within this...

Visual-estimation (cognitive), image-fusion (software) and in-bore targeted prostate biopsy: is there an optimal approach?

3 March 2021 | | Urologic Oncology, Technological Developments
The diagnostic superiority of multiparametric magnetic resonance imaging (mpMRI) prior to targeted and systematic prostate biopsy over systematic transrectal ultrasound-guided (TRUS) biopsy alone in the detection of clinically significant prostate cancer (csPCa) has been proven by multiple level 1 studies...